Company Intelligence
Parallel Bio
Parallel Bio provides enterprise-grade artificial intelligence solutions, delivering specialized Using the immune system to cure disease technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
- Headquarters
- San Francisco, United States
- Website
- parallel.bio
- Founded
- 2021
- Employees
- 20
- Stage
- Early
- Status
- Active
- Products
- 1
- Reports
- 8
- Last reviewed
- Aug 2026
Overview
What this company is, what it builds, and who it serves.
Parallel Bio is a Healthcare AI company based in San Francisco, United States, founded in 2021.
Parallel Bio develops using the immune system to cure disease.
What it builds
Using the immune system to cure disease
Why It Matters
Parallel Bio provides enterprise-grade artificial intelligence solutions, delivering specialized Using the immune system to cure disease technology designed to optimize mission-critical workflows across enterprise software developers and digital transformation teams.
Products
Products and platforms connected to this company.
-
Parallel Bio
Explore Parallel Bio by Parallel Bio. Verified AI product intelligence covering core capabilities, Healthcare use cases, technical architecture,…
View product intelligence
Ecosystem
How this company connects across the Brel AI intelligence graph.
Company
Parallel Bio
Industry
Products
Capabilities
- Using the immune system to cure disease
Country
Official Resources
Official and developer links on file for this company.
Frequently Asked Questions
What does Parallel Bio do?
Parallel Bio specializes in artificial intelligence, developing Using the immune system to cure disease to support enterprise software developers and digital transformation teams with scalable, production-grade technology.
Where is Parallel Bio based and when was it founded?
Parallel Bio is based in United States and was founded in 2021.
What are the main products offered by Parallel Bio?
The flagship platform from Parallel Bio is Using the immune system to cure disease, delivered primarily through b2b saas and enterprise api licensing.
Who are the primary target users of Parallel Bio?
Parallel Bio primarily serves enterprise software developers and digital transformation teams seeking reliable artificial intelligence implementations.
Sources & Verification
How this profile is verified and where the information comes from.
Primary sources
Request a correction if you represent this company or believe information is inaccurate.